Novo Nordisk A/S ADR buy Cantor Fitzgerald
Start price
14.02.24
/
50%
€114.00
Target price
14.02.25
€130.44
Performance (%)
9.31%
Price
27.05.24
€124.00
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald shows slight gains of 9.31%. A total of €0.61 was paid as dividends for this prediction. This prediction currently runs until 14.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | 0.813% | 0.813% |
iShares Core DAX® | -0.205% | 2.528% |
iShares Nasdaq 100 | 1.613% | 4.733% |
iShares Nikkei 225® | -0.740% | 0.396% |
iShares S&P 500 | 0.267% | 2.720% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $140.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€120.00
01.04.24
01.04.24
€148.38
01.04.25
01.04.25
3.33%
27.05.24
27.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€121.00
20.03.24
20.03.24
€147.49
20.03.25
20.03.25
2.99%
27.05.24
27.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€112.50
20.02.24
20.02.24
€129.46
20.02.25
20.02.25
10.77%
27.05.24
27.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€106.50
01.02.24
01.02.24
€128.80
01.02.25
01.02.25
17.01%
27.05.24
27.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.20
01.12.23
01.12.23
€110.39
01.12.24
01.12.24
33.71%
27.05.24
27.05.24